SWEENY NICOLE (Chief Commercial Officer) sold 8.8% of their position (3.81K shares) of KALVISTA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $51.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/4/2025ACC: 0001827505-25-000004
Officer· Chief Commercial Officer
Since Feb 2026
-3.81K
Net shares
Net seller
$51.3K
Total sold
1
Open market trades
0B · 1S
5
Total transactions
11.25K acquired · 15.06K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+6.25K
Price / share
—
Trade value
—
% of position
19.4%
11/21/2025
32.29K→38.54K
Common Stock
Direct
Shares
+5K
Price / share
—
Trade value
—
% of position
13.0%
11/22/2025
38.54K→43.54K
Common Stock
Direct
Shares
−3.81K
Price / share
$13.45
Trade value
$51.29K
% of position
8.8%
11/24/2025
43.54K→39.73K
Total
Net shares
+7.44K
Net value
-$51.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/21/2025 | M · Option Exercise | +6.25K | — | — | 19.4% | 32.29K | 38.54K |
| Common Stock Direct | 11/22/2025 | M · Option Exercise | +5K | — | — | 13.0% | 38.54K | 43.54K |
| Common Stock Direct | 11/24/2025 | S · Sale | −3.81K | $13.45 | $51.29K | 8.8% | 43.54K | 39.73K |
| Total | +7.44K | -$51.29K | ||||||
Derivative Transactions2
Restricted Stock Unit
Direct
Converts to
Common Stock
6.25K shares
Shares
−6.25K
Strike price
Held after
81.25K
Exercisable
—
11/21/2025
Restricted Stock Unit
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
Held after
50K
Exercisable
—
11/22/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock6.25K shares | 11/21/2025 | M · Option Exercise | −6.25K | — | 81.25K | |
| Restricted Stock Unit Direct | Common Stock5K shares | 11/22/2025 | M · Option Exercise | −5K | — | 50K |